Haleon Pakistan has announced a fresh investment of $12 million to expand its manufacturing capacity, focusing on scaling up ...

Pharmaceutical tariffs are coming, part of President Trump’s stated goal of bringing drug manufacturing back to the U.S.

SAP reported a remarkable 28% year-on-year increase in cloud revenue, primarily driven by the Cloud ERP Suite, which itself grew by 34% in Q2. The current cloud backlog also saw a significant rise, ...

Amid a challenging economic terrain marked by inflation, currency instability, and tepid consumer confidence, Nigeria’s capital market has defied gravity staging its most dramatic rally ever since the ...

Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways ...

A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.

British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March 2026, the company said in a notice to the state. The company said Monday ...

The pharmaceutical industry’s move toward increased U.S.-based manufacturing is changing the landscape of career ...

Just when the future looked bleak for GSK’s Blenrep comeback in the U.S., the FDA has blessed the company's multiple myeloma ...

The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.

The latest round of terminations, which will take effect Sept. 15, comes after Genentech fired more than 500 employees in the ...

On the threat of tariffs, GSK said: "The company is well positioned to respond to the potential financial impact of sector-specific tariffs, should they be implemented, with mitigation options ...